financetom
Business
financetom
/
Business
/
Snowflake Teams Up With Palantir To Make AI Work Smarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Snowflake Teams Up With Palantir To Make AI Work Smarter
Oct 16, 2025 7:26 AM

Snowflake Inc. ( SNOW ) shares are trading higher after the company disclosed a partnership with Palantir Technologies Inc. ( PLTR ) .

Deal Details

According to the agreement, Snowflake intends to integrate its AI Data Cloud with Palantir Foundry and the Palantir Artificial Intelligence Platform.

Through enhanced integration between Foundry and Snowflake Iceberg Tables, customers will gain seamless, bidirectional data access without duplication.

Also Read: Snowflake Partners With Peraton, Builds AI Fraud Detection Tools To Protect Taxpayer Dollars

Notably, Snowflake and Palantir ( PLTR ) customer Eaton is using the partnership to create an AI-ready data foundation that unifies information across systems, eliminates duplication, and strengthens governance.

The integration will enable Eaton to deploy AI agents more quickly, thereby boosting customer lifetime value, reducing churn, and lowering costs and complexity.

Management Commentary

Mike Gannon, chief revenue officer at Snowflake, said, “With this partnership, we’re providing our customers with the solutions they need today to be at the forefront of AI innovation, while also preparing them for the future by committing to close collaboration with the Palantir ( PLTR ) team to achieve their full potential through data and AI.”

Ross Schalmo, chief data officer at Eaton, stated, “With a native integration between Snowflake and Palantir ( PLTR ), two of our strategic technology partners, we eliminate tedious data movement tasks allowing us to focus on delivering outcomes ranging from agentic configuration, pricing and quoting to digital twins on our shop floor and improved servicing of our products in the field.”

Recent Events

Snowflake has entered into a strategic deal with Cognite to enable bidirectional, zero-copy data sharing between Cognite's Industrial AI and Data Platform and the Snowflake AI Data Cloud.

Investors can gain exposure to the stock via The RBB Fund Trust Twin Oak Endure ETF and Listed Funds Trust TrueShares Technology, AI & Deep Learning ETF .

Price Action: SNOW shares are up 2.67% at $247.30 at the last check on Thursday.

Read Next:

Accenture Expands AI Capabilities Through Decho Buyout, Eyes Broader Palantir Integration

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SEI Investments Insider Sold Shares Worth $11,903,333, According to a Recent SEC Filing
SEI Investments Insider Sold Shares Worth $11,903,333, According to a Recent SEC Filing
Mar 5, 2025
10:46 AM EST, 03/05/2025 (MT Newswires) -- Alfred P West Jr, Director, Executive Chairman, on March 03, 2025, sold 152,842 shares in SEI Investments ( SEIC ) for $11,903,333. Following the Form 4 filing with the SEC, West has control over a total of 7,080,080 common shares of the company, with 7,080,080 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/350894/000035089425000036/xslF345X05/wk-form4_1741189447.xml Price: 76.65,...
Cutera Files Pre-Packaged Chapter 11 to Cut Debt by $400 Million
Cutera Files Pre-Packaged Chapter 11 to Cut Debt by $400 Million
Mar 5, 2025
10:48 AM EST, 03/05/2025 (MT Newswires) -- Cutera ( CUTR ) said Wednesday it filed a pre-packaged Chapter 11 case in the US Bankruptcy Court for the Southern District of Texas to reduce its debt by about $400 million. The transaction will cut down Cutera's ( CUTR ) debt by over 90% and includes $65 million in new financing from...
TC BioPharm Reports Plan to Buy Ophthalmic Pharmaceutical Firm
TC BioPharm Reports Plan to Buy Ophthalmic Pharmaceutical Firm
Mar 5, 2025
10:49 AM EST, 03/05/2025 (MT Newswires) -- TC BioPharm ( TCBP ) said Wednesday it executed a non-binding letter of intent to acquire a commercial-stage ophthalmic pharmaceutical company in an all-stock transaction. The target company has a US Food and Drug Administration-approved once-per-day drop to decrease intraocular pressure and a pipeline of development-stage assets in ophthalmology indications, TC said. The...
SEI Investments Insider Sold Shares Worth $401,950, According to a Recent SEC Filing
SEI Investments Insider Sold Shares Worth $401,950, According to a Recent SEC Filing
Mar 5, 2025
10:47 AM EST, 03/05/2025 (MT Newswires) -- Mark Andrew Warner, on March 03, 2025, sold 5,000 shares in SEI Investments ( SEIC ) for $401,950. Following the Form 4 filing with the SEC, Warner has control over a total of 1,300 common shares of the company, with 1,300 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/350894/000035089425000034/xslF345X05/wk-form4_1741189293.xml Price: 76.64, Change: +0.36, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved